Quality of life among patients seeking treatment for substance use disorder, as measured with the EQ-5D-3L.
Kim RandEspen Ajo ArnevikEspen WalderhaugPublished in: Journal of patient-reported outcomes (2020)
SUD patients report substantially reduced HRQoL, as measured using the EQ-5D-3L. The most frequently reported problems were for the anxiety/depression, pain/discomfort, and usual activities dimensions. The EQ-5D may be a useful and practical instrument for monitoring HRQoL in SUD patients.